NL-OMON41694已完成不适用
Rosacea and the subpurpuric pulsed dye laser treatment efficacy - a randomized controlled trial - RoSE
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Subject has erythematotelangiectatic rosacea with at least 5 telangiectasia.
- •Skintype I-III according to Fitzpatrick.
排除标准
- •Subject is pregnant.
- •Presence of dermatoses that might interfere with the rosacea diagnosis or the evaluation of treatment results.
- •Subject has used isotretinoin six months prior to the first treatment session.
- •Subject is known to have a seizure disorder triggered by light.
- •Subject has suspicious pigmented lesions on the face.
研究者
相似试验
招募中
不适用
Rosacea and the Subpurpuric pulsed dye laser treatment EfficacyRosacea, Pulsed Dye Laser, Subpurpuric doseNL-OMON20185Academic Medical Center, Department of Dermatology58
已完成
不适用
Treatment of psoriasis by pulsed dye lasers: short-term and long-term (4 years) resultsISRCTN66115464Saint Louis Hospital (France)28
已完成
4 期
The efficacy of pulsed-dye laser in the treatment of post-mastectomy hypertrophic scar and keloid in transmen population: A randomized controlled trial studyHypertrophic or keloidal mastectomy scars595-nm pulsed dye laser, female-to-male transgender, hypertrophic scars, keloids, post-mastectomy, transmenTCTR20230304002Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital25
招募中
2 期
d:YAG picosecond laser treatment for melanocytic naeviJPRN-jRCTs052230007Yuki Yamamoto30
已完成
4 期
Pulse-dyed laser as an adjuvant treatment for papulopustular eruption due to epidermal growth factor receptor (EGFR) inhibitorsmales or females whose age are at least 18 yearssubjects who developed papulopustular eruption after EGFRIs initiationPapaulopustular eruption severity of grade 1 2a or 2b (Revised grading systempapulopustular eruptionepidermal growth factor receptor inhibitorspulse-dyed laserTCTR20170811002Quality Improvement Fund, King Chulalongkorn Memorial Hospital15